Font:
PP

PPLPHARMA / NSE / Biotechnology & Drugs

Piramal Pharma

INR 166.772.92 (-1.47%) 1D
Last updated: 2026-06-16T11:23:54.007726+00:00
Price Chart

1Y Price Trend

Open200.92
High220.85
Low132.3
Close167.2
Volume61,99,940
Change-33.72
Change %-16.78%

Key Information

Ticker SymbolPPLPHARMA
Current Price166.77
52-Week High220.85
52-Week Low132.3
Market Cap22,225.04
Beta1.43
Volume61,99,940
ISININE0DK501011
Day High170.85
Day Low165.39
Open166.45

Recommendations

RatingStrong Buy

Target High220.9

Target Low132.5

Target Mean1.44

Target Median55.56

Risk Metrics

Overall RiskBalanced risk

Board Risk36.95

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Stocks to buy for short term: NMDC, Bank of India among 5 stocks experts recommend for next 1-2 weeksTime unavailable
Market news

Stocks to buy for the short term: Market analysts recommend five promising stocks for the next 1-2 weeks, highlighting bullish trends and strong support zones. Stocks like Bank of India and Thyrocare Technologies show potential for growth, backed by robust technical indicators.

Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losersTime unavailable
Market news

The Indian stock market extended its losses on March 12, with the Nifty 50 and Sensex down 1% and 1.08%. Tensions in the Middle East affected investor sentiment, particularly impacting auto stocks, while broader markets showed some positive movement.

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 11 March 2026Time unavailable
Market news

Buy or sell stocks: Vaishali Parekh recommends three stocks to buy today — Piramal Pharma, Bharat Dynamics, and Oberoi Realty

Five CDMO stocks to add to your watchlistTime unavailable
Market news

Here are a list of 5 CDMO stocks that you can add to your watchlist as the industry continues to see good growth.

Piramal Pharma moves SC against Gujarat pollution body's plant closure orderTime unavailable
Market news

Piramal Pharma's plea is slated to be heard on 9 February before a bench led by Chief Justice of India Surya Kant, along with Justices Joymalya Bagchi and N.V. Anjaria.

Piramal Pharma points to early recovery signs after seeing red in Q3Time unavailable
Market news

The company posted its results for the third quarter of FY26 late on Wednesday evening, with its revenue dipping 3% year-on-year to ₹ 2,140 crore, and slipping to a loss of ₹ 136 crore from a net profit of ₹ 4 crore in Q3FY25. Its ebitda margin shrank from 16% in Q3FY25 to 11% this fiscal.

Stocks to Watch: Piramal Pharma, Honasa Consumer, NBCC, Tata Power, among 10 shares in focus todayTime unavailable
Market news

Stocks to Watch: Tata Power received a letter for Jejuri Hinjewadi Power Transmission project. Infosys completed a buyback and saw stake reductions by co-founders' kin. Adani Power is pursuing South Asian projects. Piramal Pharma addressed FDA issues, while Firstsource acquired Pastdue Credit.

Buy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday - 24 November 2025Time unavailable
Market news

Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday - Indian Energy Exchange, Piramal Pharma Ltd, and Bajaj Finance.